CLINICAL AND COST-EFFECTIVENESS OF DONEPEZIL, RIVASTIGMINE, AND GALANTAMINE FOR ALZHEIMER'S DISEASE

Volume 18
Issue 03 - Jul 2002
Add to Basket £30.00 / $45.00
Request Permissions
Cited by Articles (CrossRef)
Cited by Articles (Google Scholar)
Citation Alert
Go to Next Abstract in TOC
Go to Previous Abstract in TOC
Blog this Article close

Copy and paste this code to insert a reference to this article in your blog or online community profile:

Highlight All
<div style="background: #FFFFFF; margin: 10px 10px 10px 10px; padding: 10px 10px 10px 20px; text-align: left; border-top: 1px dashed #a5bbd1; border-left: 10px solid #a5bbd1; font-family: Verdana, Geneva, sans-serif;"><br> <div style="font-size: 12px; padding: 0px 0px 10px 0px; font-weight:bold; color: #003366;">CLINICAL AND COST-EFFECTIVENESS OF DONEPEZIL, RIVASTIGMINE, AND GALANTAMINE FOR ALZHEIMER'S DISEASE </div><br><div style="font-size: 10px;"><b>Andrew Clegg,Jackie Bryant,Tricia Nicholson,Linda McIntyre,Sofie De Broe,Karen Gerard and Norman Waugh (2002).</b><br /> <a href="http://journals.cambridge.org/action/displayJournal?jid=THC">International Journal of Technology Assessment in Health Care</a>, <a href="http://journals.cambridge.org/action/displayJournal?jid=THC&volumeId=18&bVolume=y#loc18 ">Volume 18</a>, <a href="http://journals.cambridge.org/action/displayIssue?jid=THC&volumeId=18&issueId=03&iid=135159"> Issue 03</a>, July 2002 pp 497-507 <br/> <a href="http://journals.cambridge.org/action/displayAbstract?aid=135159">http://journals.cambridge.org/action/displayAbstract?aid=135159</a></div></div>
The code will display like this:

CLINICAL AND COST-EFFECTIVENESS OF DONEPEZIL, RIVASTIGMINE, AND GALANTAMINE FOR ALZHEIMER'S DISEASE

Andrew Clegg, Jackie Bryant, Tricia Nicholson, Linda McIntyre, Sofie De Broe, Karen Gerard and Norman Waugh (2002).
International Journal of Technology Assessment in Health Care, Volume 18, Issue 03, July 2002 pp 497-507 http://journals.cambridge.org/action/displayAbstract?aid=135159

Blog this Article

International Journal of Technology Assessment in Health Care (2002), 18 : 497-507 Cambridge University Press

Copyright © 2002 Cambridge University Press

doi:10.1017/S026646230200034X (About doi)

Published online by Cambridge University Press 19 Dec 2002

Register Now

Guest

Athens Log In

Forgot your Password?

Copy and paste this link:
http://journals.cambridge.org/action/displayAbstract?aid=135159

Copy and paste this citation

Andrew Clegg, Jackie Bryant, Tricia Nicholson, Linda McIntyre, Sofie De Broe, Karen Gerard and Norman Waugh (2002). CLINICAL AND COST-EFFECTIVENESS OF DONEPEZIL, RIVASTIGMINE, AND GALANTAMINE FOR ALZHEIMER'S DISEASE . International Journal of Technology Assessment in Health Care, 18 , pp 497-507
doi:10.1017/S026646230200034X

Social Bookmarking

Username or Email Address	Password

Cambridge Journals Online

International Journal of Technology Assessment in Health Care (2002), 18 : 497-507 Cambridge University Press

Copyright © 2002 Cambridge University Press

doi:10.1017/S026646230200034X (About doi)

Published online by Cambridge University Press 19 Dec 2002